Biochemical characteristics among Mycobacterium bovis BCG substrains

被引:14
|
作者
Hayashi, Daisuke
Takii, Takemasa [1 ]
Mukai, Tetsu [2 ]
Makino, Masahiko [2 ]
Yasuda, Emi
Horita, Yasuhiro
Yamamoto, Ryuji
Fujiwara, Akiko
Kanai, Keita
Kondo, Maki
Kawarazaki, Aya
Yano, Ikuya [3 ]
Yamamoto, Saburo [3 ]
Onozaki, Kikuo
机构
[1] Nagoya City Univ, Dept Mol Hlth Sci, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan
[2] Natl Inst Infect Dis, Dept Mycobacteriol, Leprosy Res Ctr, Tokyo, Japan
[3] Japan BCG Lab, Tokyo, Japan
关键词
BCG; substrain; vaccine; biochemical characteristics; tuberculosis; NITRATE REDUCTASE NARGHJI; IN-VITRO; TUBERCULOSIS; RESISTANCE; VIRULENCE;
D O I
10.1111/j.1574-6968.2010.01947.x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In order to evaluate the biochemical characteristics of 14 substrains of Mycobacterium bovis bacillus Calmette Guerin (BCG) - Russia, Moreau, Japan, Sweden, Birkhaug, Danish, Glaxo, Mexico, Tice, Connaught, Montreal, Phipps, Australia and Pasteur - we performed eight different biochemical tests, including those for nitrate reduction, catalase, niacin accumulation, urease, Tween 80 hydrolysis, pyrazinamidase, p-amino salicylate degradation and resistance to thiophene 2-carboxylic acid hydrazide. Catalase activities of the substrains were all low. Data for nitrate reduction, niacin accumulation, Tween 80 hydrolysis, susceptibility to hydrogen peroxide and nitrate, and optimal pH for growth were all variable among these substrains. These findings suggest that the heterogeneities of biochemical characteristics are relevant to the differences in resistance of BCG substrains to environmental stress. The study also contributes to the re-evaluation of BCG substrains for use as vaccines.
引用
收藏
页码:103 / 109
页数:7
相关论文
共 50 条
  • [42] MODE OF ACTION OF KANAMYCIN ON MYCOBACTERIUM-BOVIS BCG
    KONNO, K
    OIZUMI, K
    KUMANO, N
    OKA, S
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1973, 108 (01): : 101 - 107
  • [43] Structural definition of arabinomannans from Mycobacterium bovis BCG
    Nigou, J
    Gilleron, M
    Brando, T
    Vercellone, A
    Puzo, G
    GLYCOCONJUGATE JOURNAL, 1999, 16 (06) : 257 - 264
  • [44] The role of histamine in intracellular survival of mycobacterium bovis BCG
    Buzás, K
    Megyeri, K
    Miczák, A
    Buzás, E
    Kovács, L
    Falus, A
    Mándi, Y
    TISSUE ANTIGENS, 2004, 64 (04): : 397 - 397
  • [45] Recombinant Mycobacterium bovis BCG as an HIV Vaccine Vector
    Chapman, Rosamund
    Chege, Gerald
    Shephard, Enid
    Stutz, Helen
    Williamson, Anna-Lise
    CURRENT HIV RESEARCH, 2010, 8 (04) : 282 - 298
  • [46] Multiple routes of complement activation by Mycobacterium bovis BCG
    Carroll, Maria V.
    Lack, Nathan
    Sim, Edith
    Krarup, Anders
    Sim, Robert B.
    MOLECULAR IMMUNOLOGY, 2009, 46 (16) : 3367 - 3378
  • [47] Structural definition of arabinomannans from Mycobacterium bovis BCG
    Jérôme Nigou
    Martine Gilleron
    Thérèse Brando
    Alain Vercellone
    Germain Puzo
    Glycoconjugate Journal, 1999, 16 : 257 - 264
  • [48] Mycobacterium bovis BCG induced differentiation of murine macrophages
    Hamerman, JA
    Hayashi, F
    Nelson, PS
    Hood, L
    Aderem, A
    FASEB JOURNAL, 1998, 12 (04): : A298 - A298
  • [49] Transcriptomic Analysis of Effects of Triclosan on Mycobacterium bovis BCG
    Cha, Nam Hyun
    Jang, Hyeung-Jin
    BIOCHIP JOURNAL, 2014, 8 (03) : 163 - 170
  • [50] Transcriptomic analysis of effects of triclosan on Mycobacterium bovis BCG
    Nam Hyun Cha
    Hyeung-Jin Jang
    BioChip Journal, 2014, 8 : 163 - 170